HELP Prevent Cancer Pilot Study
Not Applicable
Completed
- Conditions
- ObesityCancer
- Interventions
- Behavioral: HELP Prevent Cancer Intervention
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2020-06-19
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 21
- Registration Number
- NCT02960542
- Locations
- 🇺🇸
Danville Regional Medical Center, Danville, Virginia, United States
Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
Phase 2
Terminated
- Conditions
- EGFR Activating MutationRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
- Interventions
- Other: Laboratory Biomarker AnalysisDrug: ChemotherapyBiological: NivolumabBiological: ImmunotherapyBiological: PembrolizumabDrug: Targeted Molecular TherapyDrug: Tyrosine Kinase Inhibitor
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 19
- Registration Number
- NCT02949843
- Locations
- 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
Phase 2
Active, not recruiting
- Conditions
- Breast CancerFemale Breast Carcinoma
- Interventions
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT02942355
- Locations
- 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States
Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD
- Conditions
- Total Parenteral Nutrition-induced Cholestasis
- First Posted Date
- 2016-10-11
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT02929303
- Locations
- 🇺🇸
Advocate Children's Hospital, Park Ridge, Illinois, United States
Leukemia Stem Cell Detection in Acute Myeloid Leukemia
Phase 3
Terminated
- Conditions
- Acute Myeloid Leukemia (AML)
- Interventions
- Procedure: Allogeneic HCTDrug: Consolidation chemotherapy
- First Posted Date
- 2016-10-07
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 18
- Registration Number
- NCT02927938
- Locations
- 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States
Empowered With Movement to Prevent Obesity and Weight Regain
Not Applicable
Completed
- Conditions
- Sedentary LifestyleObesityWeight Loss
- Interventions
- Behavioral: Weight lossBehavioral: SitlessBehavioral: Exercise
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2022-03-23
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 183
- Registration Number
- NCT02923674
- Locations
- 🇺🇸
Wake Forest Baptist Health Sticht Center on Aging, Winston-Salem, North Carolina, United States
Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy
Not Applicable
Completed
- Conditions
- Bacteriuria
- Interventions
- Device: Olympus Visera Elite OTV-S190 ScopeDevice: EndoSheath CST-5000 Scope
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2018-09-12
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT02922868
- Locations
- 🇺🇸
Wake Forest Baptist Health - Department of Urology, Winston-Salem, North Carolina, United States
Assessing the Feasibility of the Use of Visual Aids in Patient Education in Adults With Down Syndrome (DS)
Not Applicable
Completed
- Conditions
- Down Syndrome
- Interventions
- Behavioral: Verbal instructions with picture diagramBehavioral: verbal instructions w. video w/DSBehavioral: Verbal instructions with video of ADSCBehavioral: verbal instructions w. video of w/o DS
- First Posted Date
- 2016-09-12
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT02895802
- Locations
- 🇺🇸
Adult Down Syndrome Center / Russell Institute for Research and Innovation, Park Ridge, Illinois, United States
Preparatory Work to Assess Adherence to Oral Chemotherapy
Completed
- Conditions
- Chronic Myeloid Leukemia
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 86
- Registration Number
- NCT02895542
- Locations
- 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
Lipiflow Versus Warm Compresses in Parkinson's Disease
Not Applicable
Withdrawn
- Conditions
- Meibomian Gland Dysfunction
- Interventions
- Procedure: Warm compressesDevice: LipiFlow system
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT02894658
© Copyright 2025. All Rights Reserved by MedPath